Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
polatuzumab vedotin b-cell antigen receptor complex-associated protein beta chain biotech NA drugbank , DGIDB Relapse[MeSHID:D012008]
Diffuse Large B-Cell Lymphoma[MeSHID:D016403]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Lymphoma
Follicular[MeSHID:D008224]
Hematologic Neoplasms[MeSHID:D019337]		 NA approved,investigational unknown
polatuzumab vedotin b-cell antigen receptor complex-associated protein beta chain biotech NA drugbank , DGIDB Relapse[MeSHID:D012008]
Diffuse Large B-Cell Lymphoma[MeSHID:D016403]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Lymphoma
Follicular[MeSHID:D008224]
Hematologic Neoplasms[MeSHID:D019337]		 NA approved,investigational antibody
polatuzumab vedotin b-cell-specific glycoprotein b29 NA Successful target TTD , DGIDB Relapse[MeSHID:D012008]
Diffuse Large B-Cell Lymphoma[MeSHID:D016403]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Lymphoma
Follicular[MeSHID:D008224]
Hematologic Neoplasms[MeSHID:D019337]		 NA approved unknown
polatuzumab vedotin b-cell-specific glycoprotein b29 NA Successful target TTD , DGIDB Relapse[MeSHID:D012008]
Diffuse Large B-Cell Lymphoma[MeSHID:D016403]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Lymphoma
Follicular[MeSHID:D008224]
Hematologic Neoplasms[MeSHID:D019337]		 NA approved antibody
click here to return to the previous page